JCAR PACKAGE WRITTEN  
COMMENTS/DHHS RESPONSE-  
UNIVERSAL BLOOD LEAD TESTING  
NAME OF PERSON PROVDING  
COMMENTS  
ORGANIZATION  
RULE NUMBER  
COMMENT  
DHHS RESPONSE  
Kenneth Rosenman, MD  
Michigan Occupation and R 330.301-Definition  
As with other public health  
requirements (i.e., communicable  
1) The statutory duty to test or order a test is imposed on physicians; the corresponding rules cannot transfer that duty to  
any other classification of health professional. This does not prevent a physician from delegating selected tasks, such  
Environmental Medical  
Association (MOEMA),  
R 330.302  
disease reporting), the law should state as performing the test, to other health professionals as allowed by law. So long as it is within the health professional’s  
that a licensed health care professional scope of practice and permitted by law, any such health professional may perform the test on behalf of a supervising  
rather than a physician is the  
professional responsible for blood lead primary medical care to many children. MDHHS will outreach to these and other health care professionals through  
testing in children. To limit the law to  
professional organizations and other channels of communication to ensure their awareness of the testing requirements.  
physician to satisfy the physician’s duty. MDHHS recognizes that Nurse Practioners and Physician's Assistants provide  
physicians does not reflect the current 2) The rules cannot limit physicians to those with patients under age 6 because the statute applies to all physicians with  
state of medical practice where nurse "minor" patients and the legal definition of "minor" is a person under the age of 18. Furthermore, because the statute  
practioners and physician assistants  
says "physician' without any qualifications, the rules cannot limit the definition of "physician" to physicians with  
provide a large percentage of medical specified medical specialties.  
care to children under the age of six,  
particularly for routine checkups and  
vaccinations. It is during these regular  
checkups that most childhood blood  
lead testing will be performed . Second,  
the law should be changed to only cover  
licensed health professional who have  
patients under the age of six. It makes  
no sense to include licensed health care  
professionals such as internists and  
gerontologists who never see children.  
Amy Zaagman, MCMCH Exe. Director Michigan Council for  
Maternal and Child Health  
General  
We support the rules as presented.  
MCMCH has been a longtime supporter  
and advocate of monitoring  
No response required.  
environmental toxins in children and  
pregnant women and participated in the  
workgroup that created the  
recommendations that guided thefinal  
language in PA 146 of 2023 and led to  
these proposed rules.  
Ashley Zuverink, on behalf of Ruth Ann Green & Healthy Homes General  
GHHI wholly supports the  
No response required.  
Norton, President & CEO  
Initiative (GHHI)  
Administrative Rule Set “Universal  
Blood Lead Testing,” MOAHR Rule  
Division No. 2023-74 HS, rules R  
330.301 - R 330.319. Childhood lead  
poisoning causes unnecessary and  
permanent effects on a child’s brain and  
organ development. No level of lead  
exposure is safe...Based on our  
experience in Maryland and other  
states, we will happily provide support  
as Michigan moves to implement  
universal lead testing.  
Colin J Ford, CEO  
Michigan Chapter of the 330.301 Rule 1 (h)  
1) Because the statute says "physician" without any qualifications, the rules cannot limit the definition of "physician" to  
physicians with specified medical specialties. 2)The statutory duty to test or order a test is imposed on physicians; the  
corresponding rules cannot transfer that duty to any other classification of health professional. This does not prevent a  
physician from delegating selected tasks, such as performing the test, to other health professionals as allowed by law.  
So long as it is within the health professional’s scope of practice and permitted by law, any such health professional  
may perform the test on behalf of a supervising physician to satisfy the physician’s duty. MDHHS recognizes that Nurse  
Practioners and Physician's Assistants provide primary medical care to many children. MDHHS will outreach to these  
and other health care professionals through professional organizations and other channels of communication to ensure  
their awareness of the testing requirements.  
330.301 Rule 1 (h) broadly defines  
physician as any individual holding a  
medical license. The proposed rule  
incorporates all allopathic or  
American Academy of  
Pediatrics  
330.302  
osteopathic physicians which may  
include physicians who are not in a  
position to effectively counsel  
parents or provide follow-up care to  
children (for example, this could  
include radiologists, pathologists,  
anesthesiologists, emergency  
medicine, etc.), additionally, this  
wording may not capture nurses or  
other licensed professionals who  
would otherwise be in a position to  
benefit from the information provided  
by testing.  
MDHHS recognizes that annual well-child visits do not always happen exactly on a child’s birth month, and we  
MIAAP supports the idea of testing or believe a reasonable interpretation of the age requirement is: ”…at around [12, 24, months]…”. This allows for  
the physician to exercise their judgement as to when to test a child who has missed the 12 or 24 month window.  
MDHHS will include this interpretation when providing job aids and conducting outreach to physicians about  
the rules.  
ordering tests for children at the ages  
of 12 and 24 months. However, there  
are some practical limitations to this  
requirement that may undercut the  
desired effect. For example, a child  
may miss or reschedule a  
twelve-month visit and be 13 months  
at the time of the visit. Additionally,  
because of the narrow wording of the  
age requirement, it is unclear what  
obligation the physician would  
have to test or order a test for the  
patient if the 12 months of age  
window is missed.  
The statute does not require that every physician test, or order a test, for every child at specified ages or risk factors.  
Rather, the statute establishes minimum mandatory blood lead testing for each child residing in Michigan; a 12-month  
test and a 24-month test and a test at other intervals depending on risk factors. This means that a physician treating a  
minor patient must ensure that the child is tested at the required ages either by testing or ordering the test for a child  
that has not yet had the test, or by verifying that the tests have occurred. MDHHS will make this clear in educational  
materials and job aids when providing education and outreach to physicians and families about the requirements in the  
rules. These materials will note that the American Academy of Physicians (AAP) recommends that blood lead testing  
should be a routine part of a child’s primary care, and compliance with Michigan’s schedule of testing requirements  
should ensure that all children who are being exposed to lead will be identified so that appropriate interventions can  
take place. It is best that blood lead testing be ordered or performed in the office of a child’s primary care physician,  
according to the testing schedule identified in the implementing rules. But recognizing that not all children are able to  
The language as currently written is  
ambiguous with respect to a child  
who has already been tested and has  
had that information entered into the  
child’s certificate of immunization.  
As currently written, the language  
appears to require any physician to  
test or order a test if the child falls  
within any of the age or risk  
categories. Children may be tested in  
settings outside of a physician office be seen by primary care physicians as recommended, the statute and rules require that any physician treating a minor  
patient must ensure these crucial tests occur. Collaboration among all providers of medical care to a child, with the  
child’s medical home as the hub, is critical to the maximal accuracy, efficiency and effectiveness of the care of the  
child and the appropriate testing of the child for lead exposure.  
such as WIC, and children may have  
multiple visits with multiple  
physicians over the course of a  
month. For example, a  
12-month old child was tested for  
lead at their WIC visit and that  
information was entered into MCIR.  
Then later that same month this child  
went to a well-child visit with their  
pediatrician, was seen by a sub-  
specialist such as a  
gastroenterologist, then later visited  
an urgent care and finally required a  
trip to an emergency room. In this  
circumstance, all  
of the physicians listed would be  
required to test or order a test for the  
child.  
1. Clarify that the testing requirement  
applies to primary care physicians,  
physicians providing routine care, or  
physicians who have an ongoing care  
relationship with the minor patient. As  
currently written, the mandate applies to  
all physicians who treat a minor  
Stacey Hettiger, Senior Director,  
Advocacy and Payor Relations  
Michigan State Medical  
Society (MSMS)  
330.301 Rule 1 (h)  
330.302  
1) Because the statute says "physician" without any qualifications, the rules cannot limit the definition of "physician" to  
physicians with specified medical specialties. 2)The statute does not require that every physician test, or order a test,  
for every child at specified ages or risk factors. Rather, the statute establishes minimum mandatory blood lead testing  
for each child residing in Michigan; a 12-month test and a 24-month test and a test at other intervals depending on risk  
factors. This means that a physician treating a minor patient must ensure that the child is tested at the required ages  
either by testing or ordering the test for a child that has not yet had the test, or by verifying that the tests have occurred.  
MDHHS will make this clear in educational materials and job aids when providing education and outreach to physicians  
and families about the requirements in the rules. These materials will note that the American Academy of Physicians  
(AAP) recommends that blood lead testing should be a routine part of a child’s primary care, and compliance with  
Michigan’s schedule of testing requirements should ensure that all children who are being exposed to lead will be  
identified so that appropriate interventions can take place. It is best that blood lead testing be ordered or performed in  
the office of a child’s primary care physician, according to the testing schedule identified in the implementing rules. But  
recognizing that not all children are able to be seen by primary care physicians as recommended, the statute and rules  
require that any physician treating a minor patient must ensure these crucial tests occur. Collaboration among all  
providers of medical care to a child, with the child’s medical home as the hub, is critical to the maximal accuracy,  
efficiency and effectiveness of the care of the child and the appropriate testing of the child for lead exposure.  
regardless of the physician’s specialty,  
whether the minor will  
return for follow-up care, or whether  
tests, counseling, and treatment are part  
of the physician’s regular practice.  
2. Clarify that a physician does not need  
to conduct or order a test if either of the  
following have occurred and been  
confirmed by checking the minor’s  
electronic immunization record in the  
Michigan electronic immunization  
information system:  
A. The minor patient has already been  
tested pursuant to the specified schedule.  
B. A case of lead poisoning has already  
been diagnosed by a physician.  
MICHIGAN OCCUPATIONAL AND ENVIRONMENTAL  
MEDICINE ASSOCIATION  
The Michigan Occupational and Environmental Medicine Association (MOEMA) appreciates the changes (i.e., CME  
and frequency of testing) made by MDHHS to the proposed draft rules to implement 2023 PA 145 and 2023 PA 146  
regarding universal lead testing. MOEMA is the state’s largest medical association dedicated to being the voice of  
occupational medicine physicians across Michigan, to promoting occupational health education and training,  
promoting health and safety of workers through prevention, advancing the cause of maintaining a cleaner and safer  
environment and is committed to the practice of ethical, evidence-based medicine.  
We understand from MDHHS’s response that in order to address our other concern on the definition of who must do  
universal blood lead testing on children that the legislature would need to amend the law. We believe these changes  
are important and recommend that MDHHS request the following amendments:  
As with other public health requirements (i.e., communicable disease reporting), the law should state that a  
licensed health care professional rather than a physician is the professional responsible for blood lead testing in  
children. To limit the law to physicians does not reflect the current state of medical practice where nurse  
practioners and physician assistants provide a large percentage of medical care to children under the age of six,  
particularly for routine checkups and vaccinations. It is during these regular checkups that most childhood blood  
lead testing will be performed.  
Second, the law should be changed to only cover licensed health professional who have patients under the age of  
six. It makes no sense to include licensed health care professionals such as internists and gerontologists who never  
see children.  
Our organization has several subject matter experts that would be more than willing to assist as needed.  
If you have questions or comments, please do not hesitate to contact us.  
MICHIGAN OCCUPATIONAL AND ENVIRONMENTAL MEDICINE ASSOCIATION  
BOARD OF DIRECTORS  
9/20/2024  
September 23, 2024  
To: Mary E. Brennan  
From: Amy Zaagman, MCMCH Executive Director  
Re: Universal Blood Lead Testing – General Rules (MOAHR #2023-74 HS)  
SUSTAINING MEMBERS  
Children’s Hospital of  
Michigan/Detroit Medical Center  
Corewell Health  
The Michigan Council for Maternal and Child Health (MCMCH) appreciates the  
opportunity to offer comments to the proposed rules for Universal Blood Lead  
Testing. MCMCH is an organization of diverse partners representing hospital  
systems, health systems, statewide organizations, local public health advocates,  
and individuals with an interest in the advancement of maternal and child health.  
Henry Ford Health System  
University of Michigan C.S. Mott  
Children’s Hospital and Von  
Voigtlander Women’s Hospital  
CONTRIBUTING MEMBERS  
Michigan Section, American  
College of Obstetricians and  
Gynecologists  
We support the rules as presented. MCMCH has been a longtime supporter and  
advocate of monitoring environmental toxins in children and pregnant women and  
we applaud Michigan’s efforts to prevent exposure to lead. We actively  
participated in the workgroup that created the recommendations that guided the  
final language in PA 146 of 2023 and led to these proposed rules.  
Mott Children’s Health Center  
School-Community Health  
Alliance of Michigan  
PARTNERING MEMBERS  
As we stated during the both the workgroup and legislative processes, we know  
prevention is ideal, but early detection and connection to services such as  
remediation, supports to address developmental delays such as the state’s Early On  
program and more intense treatments when necessary are all key parts of the  
continuum of care.  
Honor Community Health  
Michigan Association for Infant  
Mental Health  
Michigan Association of  
School Nurses  
Michigan Breastfeeding  
Network  
We believe that increasing the cadence of blood lead testing in children, especially  
those with risk factors, will result in earlier detection of elevated blood lead levels  
and are hopeful the universal blood lead testing approach will increase the number  
of children tested and identified with elevated blood lead levels earlier.  
Michigan Organization on  
Adolescent Sexual Health  
Michigan School Health  
Coordinators’ Association  
Thank you for the opportunity to comment. Please do not hesitate to contact me if  
we may provide further information or resources to support our recommendation.  
Michigan State Medical Society  
Northern Michigan Health  
Consortium  
Washtenaw County  
Public Health  
Sincerely,  
GENERAL MEMBERS  
Maternal-Newborn Nurse  
Professionals of Southeastern  
Michigan  
Amy Zaagman  
Executive Director  
Michigan Chapter, National  
Association of Pediatric  
Nurse Practitioners  
EXECUTIVE DIRECTOR  
Amy Zaagman  
106 W. Allegan Street / Suite 610 / Lansing / MI 48933 517.482.5807 mcmch.org  
Docusign Envelope ID: 8864D433-8A1F-4708-A342-0E804EE7187C  
4444 2nd Ave  
Detroit, MI 48201  
P: 313-661-3822  
F: 410-534-6475  
September 18, 2024  
Michigan Department of Health and Human Services  
MDHHS Grand Tower Building  
235 S Grand Ave 2nd Floor – Legal Affairs Administration  
Lansing, MI 48933  
To whom it may concern,  
The Green & Healthy Homes Initiative (GHHI) is a 501(c)(3) non-profit organization that  
provides advocacy, outreach, and direct prevention services. GHHI’s flagship work in Maryland  
has helped to reduce lead poisoning by 99% since 1993, when the organization was known as  
the Coalition to End Childhood Lead Poisoning. GHHI brings learnings and best practices from  
the Maryland work to sites across the country, including Michigan. GHHI has worked in  
Michigan since the early 2000s, providing support to the state and several local jurisdictions on  
lead poisoning prevention and healthy homes strategy. GHHI helped the Michigan Department  
of Health and Human Services (DHHS) develop the first state Lead Fund. GHHI also worked  
with Dr. Mona Hanna-Attisha on strategies to ensure that the crisis in Flint will not happen again.  
The GHHI Detroit office serves our mission to address the social determinants of health and  
racial equity through healthy housing through efforts to align, braid, and coordinate resources  
that address childhood lead poisoning, hazards causing injury due to trips and falls, and triggers  
to asthma among other healthy housing needs. One of GHHI’s projects is to align lead  
poisoning prevention resources with the Detroit Home Repair Fund.  
GHHI wholly supports the Administrative Rule Set “Universal Blood Lead Testing,” MOAHR Rule  
Division No. 2023-74 HS, rules R 330.301 - R 330.319. Childhood lead poisoning causes  
unnecessary and permanent effects on a child’s brain and organ development. No level of lead  
exposure is safe. GHHI was a champion of Maryland’s universal lead testing bill, Lead-Free  
Maryland Kids, which was implemented in 2016.  
We support the rule that all Michigan children will receive a blood lead test at age 1 and 2, or if  
there is no record of a previous test, between ages 2 and 6. We also support the rule to test  
children living in high-risk areas as defined in the rule set between ages 2 and 5. Blood lead  
tests are the most effective way to identify if a child has been exposed to lead, which can allow  
for swift action to prevent further exposure. We have reviewed some of the feedback on  
Michigan’s universal lead testing rule, and it is similar to feedback Maryland received before  
launching its bill. Concerns from medical providers were some of the most common points of  
contention, but none of the concerns have been borne out in the past 8 years of implementation  
of universal testing. The policy has only been beneficial by providing clarity for medical  
providers, increasing testing rates, as well as helping public health officials more readily  
understand sources of lead poisoning quickly. Maryland facilitated testing for doctors and other  
Docusign Envelope ID: 8864D433-8A1F-4708-A342-0E804EE7187C  
healthcare professionals through the promotion of point-of-care testing.1 Additionally, parents  
and caregivers are now better equipped to know as early as possible if their child has an  
elevated blood lead level so they can respond and mitigate their child’s exposure.  
Further, we support the rule requiring results of a blood lead test to be documented in a child’s  
immunization record. This will permit any physician serving the child to have appropriate access  
to the child’s lead testing history, enhancing continuity and quality of care.  
Under these rules, Michigan joins 10 states and the District of Columbia in requiring all children  
to have a blood lead test at ages 1 and 2. Together, we are improving the health of the nation’s  
children for now and generations to come.  
Based on our experience in Maryland and other states, we will happily provide support as  
Michigan moves to implement universal lead testing.  
Sincerely,  
Ruth Ann Norton  
President & CEO  
1 Article from The Baltimore Sun:  
ada3-dc7b61c93594  
1
September 24, 2024  
Mary Brennan  
Michigan Department of Health and Human Services  
South Grand Ave  
Lansing, MI 48933  
Dear Ms. Brennan,  
The Michigan Chapter of the American Academy of Pediatrics is supportive of efforts to  
adopt universal lead testing for children in Michigan. As an organization, we are  
committed to working with MDHHS and other partners to implement rules and guidance  
that are supported by the scientific evidence and reflect an intent to meaningfully improve  
identification of lead exposed children in Michigan.  
While we are supportive of the overall intent of this effort to increase lead testing among  
children, we would also like to share some specific concerns with the current language of  
the proposed rules. These suggestions are meant to attempt to better align the proposed  
rules with the current clinical guidance and practitioner experience.  
Please feel free to contact me should you have any additional questions at (517) 484-3013  
Sincerely,  
Colin J. Ford  
CEO  
09/26/2024 Lead Rules Attachment page 2  
MIAAP Comments regarding Rule Set 2023-74 HS for Universal Lead Testing  
Concerns with existing language  
Concern 1: 330.301 Rule 1 (h) broadly defines physician as any individual holding a  
medical license. The proposed rule incorporates all allopathic or osteopathic physicians  
which may include physicians who are not in a position to effectively counsel parents or  
provide follow-up care to children (for example, this could include radiologists,  
pathologists, anesthesiologists, emergency medicine, etc.), additionally, this wording may  
not capture nurses or other licensed professionals who would otherwise be in a position to  
benefit from the information provided by testing.  
Concern 2: MIAAP supports the idea of testing or ordering tests for children at the ages of  
12 and 24 months. However, there are some practical limitations to this requirement that  
may undercut the desired effect. For example, a child may miss or reschedule a  
twelve-month visit and be 13 months at the time of the visit. Additionally, because of the  
narrow wording of the age requirement, it is unclear what obligation the physician would  
have to test or order a test for the patient if the 12 months of age window is missed.  
Concern 3: The language as currently written is ambiguous with respect to a child who  
has already been tested and has had that information entered into the child’s certificate of  
immunization. As currently written, the language appears to require any physician to test  
or order a test if the child falls within any of the age or risk categories. Children may be  
tested in settings outside of a physician office such as WIC, and children may have  
multiple visits with multiple physicians over the course of a month. For example, a  
12-month old child was tested for lead at their WIC visit and that information was entered  
into MCIR. Then later that same month this child went to a well-child visit with their  
pediatrician, was seen by a sub-specialist such as a gastroenterologist, then later visited  
an urgent care and finally required a trip to an emergency room. In this circumstance, all  
of the physicians listed would be required to test or order a test for the child.  
Suggestions to address concerns  
Suggestion 1: Altering the definition of physician to better reflect the specialties or  
circumstances when testing should be ordered. Wording such as “who provide well child  
exams or primary care for minors” would be consistent with this objective. Alternatively,  
Rule 2 includes the phrasing “a physician treating a minor patient…”, therefore defining the  
term “treatment” could narrow the expectations of which physicians and in which  
circumstances should test children for lead.  
Suggestion 2: Clarify wording regarding the testing status of the child. For example, if the  
child already has a lead test contained in their certificate of immunization at 12 or 24  
MIAAP | 106 W. Allegan St, Suite 310 | Lansing, MI 48823 | (517) 484-3013 | www.miaap.org  
09/26/2024 Lead Rules Attachment page 3  
months, that child is considered tested. This could also help provide guidance to those  
physicians not in a position to counsel parents or provide follow-up care to the patient  
related to their lead exposure.  
Suggestion 3: Using the terminology 12-month visit and 24-month visit would have an  
important clarifying effect with respect to the rules. First, this would align with the  
developmental visits and could help to avoid under-testing due to technicalities of  
scheduling. Because referring to the visit as opposed to the patient age, this could also  
help provide guidance to those physicians not in a position to counsel parents or provide  
follow-up care to the patient related to their lead exposure, as these visits are generally  
within the purview of the primary care physician or provider.  
MIAAP | 106 W. Allegan St, Suite 310 | Lansing, MI 48823 | (517) 484-3013 | www.miaap.org  
PO Box 950 | East Lansing, Michigan 48826  
September 27, 2024  
Michigan Department of Health and Human Services  
Attn: Mary E. Brennan  
MDHHS Grand Tower Building  
235 S. Grand Avenue, 2nd Floor, Legal Affairs Administration  
Lansing, MI 48933  
Re:  
Rule Set 2023-74 HS, “Universal Blood Lead Testing”  
Dear Ms. Brennan:  
The Michigan State Medical Society (MSMS) appreciates the opportunity to comment on the proposed changes  
to the Universal Blood Lead Testing rule set. MSMS is a professional association representing physicians,  
residents, and medical school students from all specialties and practice settings.  
Our members support the screening of children for their risk of contact with lead hazards and subsequent lead  
poisonings. Additionally, we recognize the importance of testing for this serious health issue, especially for  
children deemed to be at high risk.  
MSMS supports the intent of the recently passed legislation and this resulting rule set. However, we respectfully  
request consideration of the following recommendations which are offered in recognition of the importance of  
care coordination and continuity of care:  
1. Clarify that the testing requirement applies to primary care physicians, physicians providing routine care, or  
physicians who have an ongoing care relationship with the minor patient. As currently written, the mandate  
applies to all physicians who treat a minor regardless of the physician’s specialty, whether the minor will  
return for follow-up care, or whether tests, counseling, and treatment are part of the physician’s regular  
practice.  
2. Clarify that a physician does not need to conduct or order a test if either of the following have occurred and  
been confirmed by checking the minor’s electronic immunization record in the Michigan electronic  
immunization information system:  
A. The minor patient has already been tested pursuant to the specified schedule.  
B. A case of lead poisoning has already been diagnosed by a physician.  
Thank you for your consideration of our comments. MSMS is committed to working with the Department and  
other partner organizations to protect Michigan’s children from lead exposure, mitigate the harms of lead  
toxicity, and ensure they have the best opportunities for achieving optimal health.  
Sincerely,  
Stacey P. Hettiger  
Senior Director, Advocacy and Payor Relations  
From:  
To:  
Subject:  
Date:  
Attachments:  
FW: Universal Blood Lead Testing Public Hearing Scheduled for Monday, September 23, 2024  
Friday, September 20, 2024 10:35:49 AM  
MOEMA 9-23 Comments on Lead regulations.pdf  
CAUTION: This is an External email. Please send suspicious emails to [email protected]  
On behalf of the Michigan Occupation and Environmental Medical Association (MOEMA), I am submitting the  
attached comments on the Universal Testing draft rules.  
Kenneth Rosenman, MD  
Secretary, Board of Directors  
MOEMA  
From: MDHHS-CLPPP <[email protected]>  
Sent: Wednesday, September 4, 2024 2:18 PM  
To: wilsonsh <[email protected]>; [email protected]; [email protected]; Jessica Grace  
<[email protected]>; Wright-Jones, Teniesha <[email protected]>; wrightr@Trinity-  
Health.org; [email protected]; Robert Van Howe (Western UP) <[email protected]>;  
<[email protected]>; Elizabeth Suggitt <[email protected]>; Melissa Hahn  
<[email protected]>; Samantha Pickering <[email protected]>; Patty Kirsch  
<[email protected]>; Colin Ford <[email protected]>; [email protected]; Ashley Zuverink  
<[email protected]>; Drautz, Anthony V <[email protected]>; Monica Rasmussen  
<Mrasmussen@waynecounty.com>  
Subject: Universal Blood Lead Testing Public Hearing Scheduled for Monday, September 23, 2024  
Dear partners in lead poisoning prevention,  
We are writing to notify you of the public hearing scheduled for Monday,  
rd  
September 23 on proposed rules implementing the 2023 law mandating blood  
lead testing of all one and two year old children and children at other ages  
depending on certain lead exposure risk factors. The notice of public hearing and  
the latest version of the rule language are both attached. Please note that  
rd  
comments on the rules may be made in person at the hearing on September 23  
th  
or by mail/e-mail until Friday, September 27 .  
This email is going to the individuals and groups who were invited to review the first  
draft of the rules in April. We thank all of you who reviewed and provided  
comments on that draft. The reviewers’ comments and our responses are also  
attached. The attached rule set includes edits made after consideration of your  
comments.  
Thank you for all your work to keep Michigan’s children safe and healthy.  
MDHHS CLPPP  
You are subscribed to Statewide EBL NCM for Michigan Dept of Health & Human Services. This  
information has recently been updated, and is now available.  
Questions? Contact Us  
SUBSCRIBER SERVICES:  
STAY CONNECTED:  
This email was sent to [email protected] using GovDelivery Communications Cloud on behalf of: Michigan Dept of Health & Human Services · 235 S.  
Grand Ave W. · Lansing, MI 48909 ·  
From:  
To:  
Subject:  
Date:  
Attachments:  
Submitting comments to 2023-74  
Friday, September 20, 2024 5:19:19 PM  
MCMCH comments to 2023-74 lead rules.pdf  
CAUTION: This is an External email. Please send suspicious emails to  
Please find MCMCH’s comments to proposed rules 2023-74 on Universal Blood Lead Testing.  
Thank you -  
Amy U. Zaagman  
Executive Director  
517-482-5807 - office  
517-230-1816 - mobile  
From:  
To:  
Cc:  
Subject:  
Date:  
Letter of Support - Universal Blood Lead Testing  
Tuesday, September 24, 2024 4:08:56 PM  
Attachments:  
image001.png  
Universal Blood Lead Testing_Michigan_GHHILOS_Signed.pdf  
CAUTION: This is an External email. Please send suspicious emails to  
Good afternoon,  
Please find an attached letter of support for the Rules on Universal Blood Lead Testing, MOAHR Rule  
Division No. 2023-74 HS, rules R 330.301 - R 330.319.  
Thank you,  
Ashley Zuverink, LMSW she/her | Program Manager - Detroit  
Green & Healthy Homes Initiative  
nd  
4444 2 Ave, Detroit, MI 48201 (Green Garage)  
(P) 313.661.3822 | [email protected]  
********************************************************************  
This e-mail and any attachments within are intended solely for the use of the addressee and may contain  
privileged, confidential, copyrighted, trademarked or other legally protected information. If you are not the intended  
recipient (even if the e-mail address above is yours), you may not use, copy or retransmit it. If you have  
received this by mistake please notify me by return e-mail, then delete. Thank you.  
********************************************************************  
From:  
To:  
Subject:  
Date:  
Attachments:  
Comments re: Administrative Rules for Universal Blood Lead Testing Rule Set 2023-74 HS  
Wednesday, September 25, 2024 1:18:32 PM  
Lead Testing final rule comments.pdf  
CAUTION: This is an External email. Please send suspicious emails to  
Please find written comments pertaining to Administrative Rules for Universal Blood Lead  
Testing Rule Set 2023-74 HS. Thanks.  
--  
Colin Ford  
Chief Executive Officer  
Michigan Chapter American Academy of Pediatrics  
106 W. Allegan, Suite 310  
Lansing, MI 48933  
P: 517.999.4050  
From:  
To:  
Subject:  
Date:  
Public Comments on Rule Set 2023-74 HS  
Friday, September 27, 2024 1:10:49 PM  
Attachments:  
image001.png  
image002.png  
image003.png  
image004.png  
image005.png  
image006.png  
MSMS Ltr_Universal Blood Lead Testing_2023-74 HS_092724.pdf  
Importance:  
High  
CAUTION: This is an External email. Please send suspicious emails to  
Hello,  
Please find attached comments from the Michigan State Medical Society on Rule Set 2023-74 HS, “Universal Blood  
Lead Testing. If you have any questions, please do not hesitate to contact me.  
Sincerely,  
Stacey  
Stacey P. Hettiger | Senior Director  
Advocacy and Payor Relations  
Michigan State Medical Society  
517-336-5766 | [email protected]rg  
;